IMAC (BACK) Competitors $0.04 +0.00 (+6.25%) As of 06/13/2025 03:52 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock BACK vs. BTTX, UPHL, ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, and TOIIWShould you be buying IMAC stock or one of its competitors? The main competitors of IMAC include Better Therapeutics (BTTX), UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), and Oncology Institute (TOIIW). These companies are all part of the "healthcare" industry. IMAC vs. Its Competitors Better Therapeutics UpHealth Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute IMAC (NASDAQ:BACK) and Better Therapeutics (NASDAQ:BTTX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, community ranking, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk. Does the MarketBeat Community believe in BACK or BTTX? Better Therapeutics received 5 more outperform votes than IMAC when rated by MarketBeat users. Likewise, 41.67% of users gave Better Therapeutics an outperform vote while only 0.00% of users gave IMAC an outperform vote. CompanyUnderperformOutperformIMACOutperform VotesNo VotesUnderperform Votes1100.00% Better TherapeuticsOutperform Votes541.67% Underperform Votes758.33% Which has stronger earnings and valuation, BACK or BTTX? IMAC has higher revenue and earnings than Better Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIMAC$72.05K1.22-$9.42MN/AN/ABetter TherapeuticsN/AN/A-$39.76MN/AN/A Do insiders & institutionals have more ownership in BACK or BTTX? 5.8% of IMAC shares are held by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are held by institutional investors. 12.3% of IMAC shares are held by insiders. Comparatively, 51.4% of Better Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility & risk, BACK or BTTX? IMAC has a beta of 2.08, indicating that its share price is 108% more volatile than the S&P 500. Comparatively, Better Therapeutics has a beta of 0.95, indicating that its share price is 5% less volatile than the S&P 500. Is BACK or BTTX more profitable? Company Net Margins Return on Equity Return on Assets IMACN/A N/A -325.44% Better Therapeutics N/A N/A N/A Does the media favor BACK or BTTX? In the previous week, IMAC had 8 more articles in the media than Better Therapeutics. MarketBeat recorded 8 mentions for IMAC and 0 mentions for Better Therapeutics. Better Therapeutics' average media sentiment score of 0.00 beat IMAC's score of -0.07 indicating that Better Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment IMAC Neutral Better Therapeutics Neutral SummaryBetter Therapeutics beats IMAC on 6 of the 10 factors compared between the two stocks. Get IMAC News Delivered to You Automatically Sign up to receive the latest news and ratings for BACK and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BACK vs. The Competition Export to ExcelMetricIMACSpecialty outpatient clinics IndustryMedical SectorNASDAQ ExchangeMarket Cap$88K$1.17B$5.57B$8.51BDividend YieldN/A1.13%5.27%4.16%P/E RatioN/A7.6526.7519.65Price / Sales1.2216.88404.17152.18Price / CashN/A8.1038.2534.64Price / Book-0.060.706.964.59Net Income-$9.42M$36.27M$3.23B$248.23M7 Day PerformanceN/A-4.98%-1.22%-1.07%1 Month PerformanceN/A-4.57%6.34%2.59%1 Year PerformanceN/A-48.34%33.05%13.50% IMAC Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BACKIMACN/A$0.04+6.3%N/A-98.2%$88K$72.05K0.00180Gap UpBTTXBetter TherapeuticsN/A$0.00flatN/AN/A$5KN/A0.0040UPHLUpHealthN/A$0.00flatN/A-100.0%$4K$130M0.001,750ACONWAclarionN/A$0.04-0.3%N/A-7.7%$0.00$54.60K0.007AONCAmerican Oncology NetworkN/A$10.55-7.9%N/A+794.3%$0.00$1.34B0.001,520High Trading VolumeDHACWDigital Health AcquisitionN/A$0.05flatN/A-76.3%$0.00N/A0.00N/ALFMDPLifeMDN/A$23.89+2.6%N/A+3.8%$0.00$234.01M0.00230Positive NewsShort Interest ↓OTRKPOntrakN/A$0.24+8.5%N/A-28.5%$0.00$10.84M0.00250Gap UpPIIIWP3 Health PartnersN/A$0.01-28.7%N/A-86.6%$0.00$1.49B0.00500Gap DownHigh Trading VolumeTALKWTalkspaceN/A$0.09-6.2%N/A-40.1%$0.00$194.36M0.00500Short Interest ↑TOIIWOncology InstituteN/A$0.07-9.4%N/A+187.3%$0.00$403.15M0.00660Positive NewsShort Interest ↑Gap Down Related Companies and Tools Related Companies Better Therapeutics Competitors UpHealth Competitors Aclarion Competitors American Oncology Network Competitors Digital Health Acquisition Competitors LifeMD Competitors Ontrak Competitors P3 Health Partners Competitors Talkspace Competitors Oncology Institute Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BACK) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMAC Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMAC With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
